BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31662968)

  • 41. Indirect Evaluation of Bone Saturation with Zoledronic Acid After Long-Term Dosing.
    Hortobagyi GN; Zheng M; Mohanlal R
    Oncologist; 2019 Feb; 24(2):178-184. PubMed ID: 30297386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats.
    Little DG; Peat RA; Mcevoy A; Williams PR; Smith EJ; Baldock PA
    J Bone Miner Res; 2003 Nov; 18(11):2016-22. PubMed ID: 14606515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized Controlled Trial Evaluating the Use of Zoledronic Acid in Duchenne Muscular Dystrophy.
    Zacharin M; Lim A; Gryllakis J; Siafarikas A; Jefferies C; Briody J; Heather N; Pitkin J; Emmanuel J; Lee KJ; Wang X; Simm PJ; Munns CF
    J Clin Endocrinol Metab; 2021 Jul; 106(8):2328-2342. PubMed ID: 33954789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of simvastatin administration on periodontitis-associated bone loss in ovariectomized rats.
    Vaziri H; Naserhojjati-Roodsari R; Tahsili-Fahadan N; Khojasteh A; Mashhadi-Abbas F; Eslami B; Dehpour AR
    J Periodontol; 2007 Aug; 78(8):1561-7. PubMed ID: 17668976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effects of anti-RANKL monoclonal antibody and zoledronic acid on necrotic bone in a murine model of Staphylococcus aureus-induced osteomyelitis.
    Kobayashi H; Fujita R; Hiratsuka S; Shimizu T; Sato D; Hamano H; Iwasaki N; Takahata M
    J Orthop Res; 2022 Mar; 40(3):614-623. PubMed ID: 33990977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of short-term zoledronic acid treatment on bone remodeling and healing at surgical sites in the maxilla and mandible of aged dogs.
    Huja SS; Mason A; Fenell CE; Mo X; Hueni S; D'Atri AM; Fernandez SA
    J Oral Maxillofac Surg; 2011 Feb; 69(2):418-27. PubMed ID: 21122971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Menaquinone-4 prevents medication-related osteonecrosis of the jaw through the SIRT1 signaling-mediated inhibition of cellular metabolic stresses-induced osteoblast apoptosis.
    Cui Y; Zhang W; Yang P; Zhu S; Luo S; Li M
    Free Radic Biol Med; 2023 Sep; 206():33-49. PubMed ID: 37364692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial.
    Westin JR; Thompson MA; Cataldo VD; Fayad LE; Fowler N; Fanale MA; Neelapu S; Samaniego F; Romaguera J; Shah J; McLaughlin P; Pro B; Kwak LW; Sanjorjo P; Murphy WA; Jimenez C; Toth B; Dong W; Hagemeister FB
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):99-105. PubMed ID: 23276888
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Photodynamic therapy and photobiomodulation therapy in zoledronic acid-induced osteonecrosis in rats.
    Silva PGB; Praxedes Neto RALP; Lima LA; Lemos JVM; Rodrigues MIQ; Alves APNN; Dantas TS; Lima RA
    Photodiagnosis Photodyn Ther; 2022 Jun; 38():102889. PubMed ID: 35489689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of Vascular Morphometry in Jawbones and Long Bones: Micro-CT Study in a Rat Model Treated with Zoledronic Acid.
    Wang JY; Yu RQ; Huo L; Rao NJ; Lu WW; Zheng LW
    Biomed Res Int; 2021; 2021():6651318. PubMed ID: 34055992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of different doses of teriparatide on bisphosphonate-related osteonecrosis of the jaw in mice.
    Yu W; Su J
    Oral Dis; 2020 Apr; 26(3):609-620. PubMed ID: 31903673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Negative effect of zoledronic acid on tendon-to-bone healing.
    Hjorthaug GA; Søreide E; Nordsletten L; Madsen JE; Reinholt FP; Niratisairak S; Dimmen S
    Acta Orthop; 2018 Jun; 89(3):360-366. PubMed ID: 29493345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of bone morphometric changes on orthodontic tooth movement in an osteoporotic animal model.
    Hashimoto M; Hotokezaka H; Sirisoontorn I; Nakano T; Arita K; Tanaka M; Yoshida N
    Angle Orthod; 2013 Sep; 83(5):766-73. PubMed ID: 23445276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
    Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
    Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early bony changes associated with bisphosphonate-related osteonecrosis of the jaws in rats: A longitudinal in vivo study.
    Vilarinho JLP; Ferrare N; Moreira AMR; Moura HF; Acevedo AC; Chaves SB; Melo NS; Leite AF; Macedo SB; de Souza MP; Guimarães ATB; Figueiredo PT
    Arch Oral Biol; 2017 Oct; 82():79-85. PubMed ID: 28622548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bis‑enoxacin blocks alveolar bone resorption in rats with ovariectomy‑induced osteoporosis.
    Zhang X; Xu X; Liu X; Mao C; Qin A; Lu E
    Mol Med Rep; 2018 Feb; 17(2):3232-3238. PubMed ID: 29257280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Zoledronate reverses mandibular bone loss in osteoprotegerin-deficient mice.
    Sheng ZF; Xu K; Ma YL; Liu JH; Dai RC; Zhang YH; Jiang YB; Liao EY
    Osteoporos Int; 2009 Jan; 20(1):151-9. PubMed ID: 18496637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score-matched analysis.
    Ikesue H; Doi K; Morimoto M; Hirabatake M; Muroi N; Yamamoto S; Takenobu T; Hashida T
    Support Care Cancer; 2022 Mar; 30(3):2341-2348. PubMed ID: 34738163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zoledronic acid decreases bone formation without causing osteocyte death in mice.
    Huja SS; Fernandez SA; Phillips C; Li Y
    Arch Oral Biol; 2009 Sep; 54(9):851-6. PubMed ID: 19591974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental evaluation of the effects of zoledronic acid on regenerate bone formation and osteoporosis in mandibular distraction osteogenesis.
    Pampu AA; Dolanmaz D; Tüz HH; Karabacakoglu A
    J Oral Maxillofac Surg; 2006 Aug; 64(8):1232-6. PubMed ID: 16860215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.